Page last updated: 2024-11-04

sulforaphane and Epidermolysis Bullosa Simplex

sulforaphane has been researched along with Epidermolysis Bullosa Simplex in 1 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Epidermolysis Bullosa Simplex: A form of epidermolysis bullosa characterized by serous bullae that heal without scarring. Mutations in the genes that encode KERATIN-5 and KERATIN-14 have been associated with several subtypes of epidermolysis bullosa simplex.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kerns, ML1
DePianto, D1
Dinkova-Kostova, AT1
Talalay, P1
Coulombe, PA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure[NCT03730649]Early Phase 1120 participants (Anticipated)Interventional2019-10-09Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for sulforaphane and Epidermolysis Bullosa Simplex

ArticleYear
Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Sep-04, Volume: 104, Issue:36

    Topics: Animals; Animals, Newborn; Blister; Epidermolysis Bullosa Simplex; Gene Expression Regulation; Isoth

2007